Further Investigation Into an Environmental Source for Aminorex.

Overview

• This study investigates the environmental sources of aminorex detected in racehorses, focusing on plant-derived precursors rather than the drug levamisole.
• It identifies resedine as a key intermediary compound linking certain plants to aminorex presence in horses, providing a potential biomarker to differentiate environmental from drug-related aminorex positives.

Background

• Aminorex is a stimulant controlled in equine sports due to its performance-enhancing effects.
• In 2009, levamisole, a common veterinary drug, was found to metabolize into aminorex, explaining some positive test results in horses.
• Despite this, aminorex positives continue to occur with no direct evidence of levamisole use, indicating other sources may exist.
• Previous research highlighted barbarin, a compound in plants of the Brassicaceae family, as a potential precursor to aminorex.
• The Brassicaceae family includes certain plants commonly found in horse forage or environment.

Study Objectives

• To explore if barbarin, found in Brassicaceae plants, is linked to aminorex production in horses.
• To identify additional biomarkers that originate from plants and may explain aminorex detection.

Methods

• Analytical methods were developed and validated to detect aminorex, barbarin, glucobarbarin (a related compound), and other associated chemicals in biological samples.
• One horse was administered aminorex directly to study its metabolism; barbarin was not found in that horse’s plasma or urine, indicating it is not a downstream metabolite of aminorex.
• Two horses were given plants Barbarea stricta and Barbarea orthoceras, both from the Brassicaceae family.
• Samples of plasma and urine from these horses were collected and analyzed for aminorex and related compounds.
• Retrospective chromatogram analysis was used to identify additional compounds present before and after administration.
• A separate administration of resedine, a compound detected from plant material, was performed on one horse to further investigate its metabolism.

Key Results

• After aminorex administration, barbarin was not detected in horse plasma or urine, suggesting aminorex does not metabolize into barbarin.
• Following administration of Brassicaceae plants, aminorex was consistently detected in all plasma and urine samples.
• Barbarin was detected in some plasma samples but was absent in urine.
• Resedine was identified in plant materials and appeared consistently in plasma and urine samples after the plant administration in horses.
• When resedine was administered to a horse, it was detected in both plasma and urine, but aminorex was only found in urine samples.

Interpretation and Significance

• Resedine acts as an intermediate metabolite, converting from barbarin after ingestion of Brassicaceae plants and then further metabolizing into aminorex within horses.
• The presence of resedine can be used as a biomarker to identify whether aminorex detected in horses originates from environmental plant ingestion rather than illicit drug use.
• This offers a more accurate interpretation of aminorex positives in equine drug testing, avoiding false penalties when the source is dietary.
• The study thus suggests a biochemical pathway: Barbarin (from plants) → Resedine → Aminorex (detected in urine/plasma).
• This discovery helps regulatory bodies distinguish contamination from doping, improving fairness in horse racing competitions.

Conclusions

• Brassicaceae plants can contribute to aminorex detections in horses via metabolic conversion involving resedine.
• Resedine is a reliable marker to differentiate environmental aminorex positives from those caused by levamisole or other drug sources.
• Understanding this pathway will aid in refining equine drug testing protocols and interpretation standards.